These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 26003067

  • 1. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
    Woś H, Sankiewicz-Szkółka M, Więcek S, Kordys-Darmolińska B, Grzybowska-Chlebowczyk U, Kniażewska M.
    Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
    [Abstract] [Full Text] [Related]

  • 2. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D, Zybert K, Mierzejewska E, Ołtarzewski M.
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [Abstract] [Full Text] [Related]

  • 3. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.
    BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149
    [Abstract] [Full Text] [Related]

  • 4. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I, Girodon E, Roussel D, Deneuville E, Bui S, Huet F, Guillot M, Aboutaam R, Renouil M, Munck A, des Georges M, Iron A, Thauvin-Robinet C, Fajac I, Lenoir G, Roussey M, Edelman A.
    Thorax; 2010 Jun 03; 65(6):539-44. PubMed ID: 20522854
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN, Nussbaum E, Chin TW, Do PC, Singh KE, Randhawa I.
    Pediatr Pulmonol; 2014 Mar 03; 49(3):E103-8. PubMed ID: 24535988
    [Abstract] [Full Text] [Related]

  • 6. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R, Bassotti A, Seia M, Corbetta C.
    Eur J Pediatr; 2002 Apr 03; 161(4):212-5. PubMed ID: 12014388
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL, Desai H, Platt M, Dixon M.
    Pediatr Pulmonol; 2011 Nov 03; 46(11):1079-84. PubMed ID: 21538969
    [Abstract] [Full Text] [Related]

  • 8. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U, Moatter T.
    J Ayub Med Coll Abbottabad; 2006 Nov 03; 18(1):7-10. PubMed ID: 16773960
    [Abstract] [Full Text] [Related]

  • 9. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN, Foster MM, Newman NB, Anbar RD.
    J Pediatr; 2008 Dec 03; 153(6):857-9. PubMed ID: 19014821
    [Abstract] [Full Text] [Related]

  • 10. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C, ECFS CF Neonatal Screening Working Group.
    J Cyst Fibros; 2007 Jan 03; 6(1):57-65. PubMed ID: 16870510
    [Abstract] [Full Text] [Related]

  • 11. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C, Seia M, Bassotti A, Ambrosioni A, Giunta A, Padoan R.
    J Med Screen; 2002 Jan 03; 9(2):60-3. PubMed ID: 12133923
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB, Comeau AM.
    J Pediatr; 2005 Sep 03; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [Abstract] [Full Text] [Related]

  • 13. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK, Hammond KB, Zielenski J, Wagener JS, Accurso FJ.
    J Pediatr; 2005 Sep 03; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [Abstract] [Full Text] [Related]

  • 14. CF versus CRMS: diagnostic challenges in cystic fibrosis.
    Temme R, Roggenbuck J, McNamara J.
    Minn Med; 2012 Oct 03; 95(10):42-4. PubMed ID: 23193705
    [Abstract] [Full Text] [Related]

  • 15. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.
    Pediatrics; 2004 Jun 03; 113(6):1573-81. PubMed ID: 15173476
    [Abstract] [Full Text] [Related]

  • 16. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM.
    Clin Genet; 2016 May 03; 89(5):539-49. PubMed ID: 26671754
    [Abstract] [Full Text] [Related]

  • 17. [Neonatal screening for cystic fibrosis].
    Tellería Orriols JJ, Alonso Ramos MJ, Garrote Adrados JA, Fernández Carvajal I, Blanco Quirós A.
    An Esp Pediatr; 2002 Jul 03; 57(1):60-5. PubMed ID: 12139895
    [Abstract] [Full Text] [Related]

  • 18. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L, Ferraguti G, Stamato A, Narzi F, Valentini SB, Lelli A, Delaroche I, Lucarelli M, Strom R, Quattrucci S.
    Clin Genet; 2007 Jul 03; 72(1):39-46. PubMed ID: 17594398
    [Abstract] [Full Text] [Related]

  • 19. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM.
    J Pediatr; 2005 Sep 03; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [Abstract] [Full Text] [Related]

  • 20. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
    Keiles S, Koepke R, Parad R, Kharrazi M, California Cystic Fibrosis Newborn Screening Consortium.
    J Cyst Fibros; 2012 May 03; 11(3):257-60. PubMed ID: 22209734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.